Individualized cognitive-behavioral therapy improves anxiety, depression, sleep quality, hopelessness, and disease severity in fibromyalgia syndrome: a single-blind randomized controlled trial
Overview
This single-blind randomized controlled trial examines the effects of adding a 10-week individualized cognitive-behavioral therapy program to routine treatment for patients with fibromyalgia syndrome. The study reports statistically significant improvements in anxiety, depression, sleep quality, hopelessness, and disease severity among participants who received the intervention compared to those receiving only standard care.
- ID
4ee106242d194da8- Source org
- PubMed Central
- Author
- Burhan Fatih Koçyiğit (Sağlık Bilimleri Üniversitesi), Gülşah Yaşa Öztürk (Sağlık Bilimleri Üniversitesi), Mehmet Macit Sönmez, Saltanat K. Yerkebayeva (South Kazakhstan Medical Academy), Meirgul I. Assylbek (South Kazakhstan Medical Academy)
- Published
- 2026-05-26
- OA status
- hybrid
- DOI
- 10.1007/s00296-026-06146-9
- PMID
- Not recorded
- PMCID
- Not recorded
- Citations
- 1
Tags
Verification
- identityok via crossref · score 1 · checked_at unknown
- legitimacykeep via unknown · score 1 · checked_at unknown
- linkok via http-check · 2026-07-21T15:52:31.592259+00:00
Cite this entry
BibTeX
@article{allodium:4ee106242d194da8,
title = {Individualized cognitive-behavioral therapy improves anxiety, depression, sleep quality, hopelessness, and disease severity in fibromyalgia syndrome: a single-blind randomized controlled trial},
author = {Burhan Fatih Koçyiğit and Gülşah Yaşa Öztürk and Mehmet Macit Sönmez and Saltanat K. Yerkebayeva and Meirgul I. Assylbek},
year = {2026},
journal = {PubMed Central},
doi = {10.1007/s00296-026-06146-9},
url = {https://doi.org/10.1007/s00296-026-06146-9}
}RIS
TY - JOUR TI - Individualized cognitive-behavioral therapy improves anxiety, depression, sleep quality, hopelessness, and disease severity in fibromyalgia syndrome: a single-blind randomized controlled trial AU - Koçyiğit, Burhan Fatih AU - Öztürk, Gülşah Yaşa AU - Sönmez, Mehmet Macit AU - Yerkebayeva, Saltanat K. AU - Assylbek, Meirgul I. PY - 2026 PB - PubMed Central DO - 10.1007/s00296-026-06146-9 UR - https://doi.org/10.1007/s00296-026-06146-9 ER -
APA
Koçyiğit, B. F., Öztürk, G. Y., Sönmez, M. M., Yerkebayeva, S. K., & Assylbek, M. I. (2026). Individualized cognitive-behavioral therapy improves anxiety, depression, sleep quality, hopelessness, and disease severity in fibromyalgia syndrome: a single-blind randomized controlled trial. PubMed Central. https://doi.org/10.1007/s00296-026-06146-9
Related entries
- Efficacy of Cognitive-Behavioral Therapies in Fibromyalgia Syndrome — A Systematic Review and Metaanalysis of Randomized Controlled Trials
- Cognitive behavioural therapies for fibromyalgia
- Cognitive behavioral therapy for the treatment of juvenile fibromyalgia: A multisite, single‐blind, randomized, controlled clinical trial
- Cognitive-behavioral therapy and acceptance and commitment therapy for anxiety and depression in patients with fibromyalgia: a systematic review and meta-analysis
- Emotional awareness and expression therapy, cognitive behavioral therapy, and education for fibromyalgia: a cluster-randomized controlled trial
- Efficacy, acceptability and safety of cognitive behavioural therapies in fibromyalgia syndrome – A systematic review and meta‐analysis of randomized controlled trials
- Mindfulness- and acceptance-based interventions for patients with fibromyalgia – A systematic review and meta-analyses
- A Systematic Review and Meta‐Analysis Examining the Effect of Mindfulness Based Stress Reduction on Pain Severity and Quality of Life in People Living With Fibromyalgia
- Brief Acceptance and Commitment Therapy for Fibromyalgia: Feasibility and Effectiveness of a Replicated Single-Case Design
- Psychodynamic Interventions for Fibromyalgia: A Systematic Review